New Anti-Obesity Meds and ECT: LTE in JECT

Out on PubMed, in JECT, is this LTE:

Reply to "Glucagon-Like Peptide-1 Receptor Agonists During Electroconvulsive Therapy: Case Report With Evolving Concerns and Management Considerations".
Jacobi D.J ECT. 2024 Jul 10. doi: 10.1097/YCT.0000000000001053. Online ahead of print.

PMID: 38984842  

The LTE is here:


Here is an LTE about management strategies for ECT patients on the new GLP-1 receptor agonists. The issue is delayed gastric emptying and the risk of aspiration.

I think we are still in a period in which we are learning how much of an actual clinical risk this really is.


Please see also:

Glucagon-Like Peptide-1 Receptor Agonists During Electroconvulsive Therapy: Case Report With Evolving Concerns and Management Considerations.

Espinoza RT, Antongiorgi Z.J ECT. 2024 Feb 2. doi: 10.1097/YCT.0000000000000992. Online ahead of print.PMID: 38315827

Comments

Popular posts from this blog

ECT plus Antidepressants: a Review

Clinical Phenotype of Behavioral-Variant Frontotemporal Dementia Reversed by ECT: A Case Report

Early Use of the Name "ECT"- Sacklers in 1949